Preconditioning the myocardium: from cellular physiology to clinical cardiology
Yellon, Derek M., and James M. Downey. Preconditioning the Myocardium: From Cellular
Physiology to Clinical Cardiology. Physiol Rev 83: 1113-1151, 2003; 10.1152/physrev …
Physiology to Clinical Cardiology. Physiol Rev 83: 1113-1151, 2003; 10.1152/physrev …
Exercise preconditioning as a cardioprotective phenotype
JC Quindry, BA Franklin - The American journal of cardiology, 2021 - Elsevier
Cardiovascular disease (CVD) is potentiated by risk factors including physical inactivity and
remains a leading cause of morbidity and mortality. Although regular physical activity does …
remains a leading cause of morbidity and mortality. Although regular physical activity does …
The preconditioning phenomenon: a tool for the scientist or a clinical reality?
DM Yellon, A Dana - Circulation research, 2000 - Am Heart Assoc
The possibility that an innate mechanism of myocardial protection might be inducible in the
human heart has generated considerable excitement and enthusiastic research. The …
human heart has generated considerable excitement and enthusiastic research. The …
ATP-sensitive potassium channels
GC Rodrigo, NB Standen - Current pharmaceutical design, 2005 - ingentaconnect.com
ATP-sensitive potassium (KATP) channels link membrane excitability to metabolism. They
are regulated by intracellular nucleotides and by other factors including membrane …
are regulated by intracellular nucleotides and by other factors including membrane …
[HTML][HTML] The potential effects of anti-diabetic medications on myocardial ischemia–reperfusion injury
Y Ye, JR Perez-Polo, D Aguilar, Y Birnbaum - Basic research in cardiology, 2011 - Springer
Heart disease and stroke account for 65% of the deaths in people with diabetes mellitus
(DM). DM and hyperglycemia cause systemic inflammation, endothelial dysfunction, a …
(DM). DM and hyperglycemia cause systemic inflammation, endothelial dysfunction, a …
复方丹参方预处理对心肌缺血再灌注损伤的保护作用
高秀梅， 张伯礼， 商洪才， 王怡， 郭利平， 张萌， 史红… - 中国临床康复, 2003 - cqvip.com
目的观察复方丹参方预处理冠脉结所经典大鼠, 验证其是否具有模拟或加强缺血预适应减少缺血
再灌后折损伤后的作用. 方法180 只大鼠采用Stata 统计软件随机分为9 组, 每组各20 只 …
再灌后折损伤后的作用. 方法180 只大鼠采用Stata 统计软件随机分为9 组, 每组各20 只 …
Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications
JP Riveline, N Danchin, F Ledru, M Varroud-Vial… - Diabetes & …, 2003 - Elsevier
OBJECTIVES: 33 years after the UGDP study, the question of deleterious effects of the
sulfoylurea (SU) is still raised. We have made a systematic review of the literature from …
sulfoylurea (SU) is still raised. We have made a systematic review of the literature from …
Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection
Cardiovascular disease, predominantly ischemic heart disease (IHD), is the leading cause
of death in diabetes mellitus (DM). In addition to eliciting cardiomyopathy, DM induces a …
of death in diabetes mellitus (DM). In addition to eliciting cardiomyopathy, DM induces a …
Pro-and antiarrhythmic actions of sulfonylureas: mechanistic and clinical evidence
Sulfonylureas are the most commonly used second-line drug class for treating type 2
diabetes mellitus (T2DM). While the cardiovascular safety of sulfonylureas has been …
diabetes mellitus (T2DM). While the cardiovascular safety of sulfonylureas has been …
'Conditioning'the heart during surgery
V Venugopal, A Ludman, DM Yellon… - European journal of …, 2009 - academic.oup.com
Coronary heart disease (CHD) is the leading cause of death worldwide. Coronary artery
bypass graft (CABG) surgery remains the procedure of choice for coronary artery …
bypass graft (CABG) surgery remains the procedure of choice for coronary artery …